A Study of Bitopertin (RO4917838) in Healthy Male Volunteers

Trial Profile

A Study of Bitopertin (RO4917838) in Healthy Male Volunteers

Phase of Trial: Phase I

Latest Information Update: 14 Sep 2015

At a glance

  • Drugs Bitopertin (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 12 Jul 2012 New source identified and integrated (ClinicalTrials.gov record NCT01636492).
    • 19 Apr 2012 Results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 19 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top